Dr. William A. Kaye, MD

Dr. Kaye practices at Palm Beach Diabetes and Endocrine Specialists PA in West Palm Beach, Florida.

Dr. Kaye's NPI, 1003820002, was assigned on July 28, 2006. Dr. Kaye graduated from The Warren Alpert Medical School of Brown University in 1976. Dr. Kaye holds Florida license ME0047592.

Dr. Kaye's primary practice is Palm Beach Diabetes and Endocrine Specialists PA, at 1515 N Flagler Dr, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (561) 659-6336.

Dr. Kaye's primary practice is Palm Beach Diabetes and Endocrine Specialists PA in West Palm Beach, Florida. Dr. Kaye is also affiliated with Good Samaritan Medical Center. The medical group on file is Palm Beach Diabetes & Endocrine Specialists, PA. Dmand AI also links Dr. Kaye to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaye practices, 3 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Kaye's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Kaye is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Kaye's licenses on file in 3 states: Florida, California and Rhode Island.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, high cholesterol, hypercalcemia, obesity and osteoporosis among the conditions Dr. Kaye treats.

CMS data shows 30,668 Medicare services from Dr. Kaye across 57 procedure codes in 2024, for 1,072 Medicare patients. Medicare paid $692,142 for them. Every service was in an office.

CMS counts 1,072 Medicare patients who saw Dr. Kaye in 2024. The largest group is 75 to 84, with 460 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaye's median patient age at 64, with 60% women.

In 2024, Dr. Kaye wrote 8,458 Medicare Part D claims for 995 patients. 44% of them were for generic drugs. CMS names the drug for 7,975 of them, across 92 drugs with 11 or more claims each, at $3,739,755 in total drug cost. In 2023, CMS named 7,435 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kaye for performance year 2024, reported as part of a group. Dr. Kaye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaye as offering telehealth.

Dmand AI links 38 papers to Dr. Kaye, published from 2010 to 2021. The most frequent topics are Cardiopulmonary Resuscitation, Heart Arrest and Resuscitation. Dr. Kaye has published most often in Resuscitation. Dr. Kaye's most frequent co-authors are Robert A. Berg, MD, Maxwell Ethan Horowitz, DO and Robert J. Boland, MD.

Dmand AI links Dr. Kaye to 2 clinical trials. Conditions studied include Diabetes Mellitus, Type 2, Hyperalgesia and Diabetes Mellitus. Open Payments lists research payments to Dr. Kaye that name 1 trial.

CMS Open Payments shows 1,646 general payments to Dr. Kaye from 77 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 85% of the total. Eli Lilly and Company paid the most, $257,781. It also lists 3 research payments totaling $3,557 from 2016 to 2017, naming 1 clinical trial.

Dmand AI lists 5 awards for Dr. Kaye, most recently Gulfstream FL-Palm Beach in 2014.

Dr. Kaye graduated from The Warren Alpert Medical School of Brown University in 1976.

Dr. Kaye is in network with 12 carriers, including Aetna, United Healthcare and Cigna. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.